Embla Medical (formerly Össur) is an Iceland-based medtech group specializing in non-invasive orthopedics and prosthetics. It designs artificial limbs, braces and supports used by amputees and people with musculoskeletal conditions, sold through clinicians and healthcare channels worldwide. The company is known for combining mechanical and microprocessor-controlled prosthetic technologies under long-standing clinical brands.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q4 2024 | 224.8 | — | 18.2 | — |
| Q1 2025 | 202.8 | — | 12.2 | — |
| Q2 2025 | 232.4 | — | 20.9 | — |
| Q4 2025 | 256.7 | 14.2% | 24.4 | 34% |
| Q1 2026 | 232.4 | 14.6% | 14.5 | 18.9% |
| Q2 2026 | 258.6 | 11.3% | 29.2 | 39.8% |
All markets — KeepWinning global stock screener
Other companies on Copenhagen: UIE Plc (UIE), Jeudan A/S (JDAN), Dampskibsselskabet Norden A/S (DNORD), ChemoMetec A/S (CHEMM), DFDS A/S (DFDS), SJF Bank A/S (SJF)